ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $124,600 | +34.0% | 11,379 | +34.0% | 0.00% | 0.0% |
| Q3 2023 | $93,009 | -27.0% | 8,494 | -11.7% | 0.00% | 0.0% |
| Q2 2023 | $127,422 | -77.1% | 9,624 | -66.3% | 0.00% | -81.2% |
| Q4 2022 | $557,210 | +6.1% | 28,531 | +3.4% | 0.02% | -5.9% |
| Q3 2022 | $525,000 | +16.4% | 27,581 | +26.1% | 0.02% | +30.8% |
| Q2 2022 | $451,000 | -33.6% | 21,878 | +3.6% | 0.01% | -7.1% |
| Q1 2022 | $679,000 | – | 21,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |